SETD2 and colorectal cancer: In their clinical and histopathological study of SETD2 in colorectal cancer, Bushara et al. thus reported that SETD2-mutated CRC affects the proximal and distal colon with equal frequency and that most of the mutations are missense without any “hotspot” mutation sites within the SETD2 gene.